JP4381820B2 - 生体組織検査用マイクロ抽出装置 - Google Patents
生体組織検査用マイクロ抽出装置 Download PDFInfo
- Publication number
- JP4381820B2 JP4381820B2 JP2003574050A JP2003574050A JP4381820B2 JP 4381820 B2 JP4381820 B2 JP 4381820B2 JP 2003574050 A JP2003574050 A JP 2003574050A JP 2003574050 A JP2003574050 A JP 2003574050A JP 4381820 B2 JP4381820 B2 JP 4381820B2
- Authority
- JP
- Japan
- Prior art keywords
- fiber
- extraction
- sample
- coated
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000605 extraction Methods 0.000 claims abstract description 181
- 239000000835 fiber Substances 0.000 claims description 327
- 239000012071 phase Substances 0.000 claims description 120
- 238000005070 sampling Methods 0.000 claims description 80
- 241001465754 Metazoa Species 0.000 claims description 76
- 238000000576 coating method Methods 0.000 claims description 64
- 239000011248 coating agent Substances 0.000 claims description 55
- 238000002470 solid-phase micro-extraction Methods 0.000 claims description 42
- 239000002904 solvent Substances 0.000 claims description 40
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 32
- 229920000642 polymer Polymers 0.000 claims description 25
- 210000004204 blood vessel Anatomy 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 24
- 229920000128 polypyrrole Polymers 0.000 claims description 24
- 239000010410 layer Substances 0.000 claims description 12
- 229920001223 polyethylene glycol Polymers 0.000 claims description 9
- 229920000058 polyacrylate Polymers 0.000 claims description 8
- 230000014759 maintenance of location Effects 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 210000004102 animal cell Anatomy 0.000 claims description 4
- 230000001413 cellular effect Effects 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000011241 protective layer Substances 0.000 claims description 3
- 229920000344 molecularly imprinted polymer Polymers 0.000 claims description 2
- 229920000779 poly(divinylbenzene) Polymers 0.000 claims 1
- 238000011002 quantification Methods 0.000 abstract description 29
- 238000001727 in vivo Methods 0.000 abstract description 15
- 238000012544 monitoring process Methods 0.000 abstract description 8
- 238000013459 approach Methods 0.000 abstract description 2
- 238000011835 investigation Methods 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 161
- 238000000034 method Methods 0.000 description 134
- 238000004458 analytical method Methods 0.000 description 81
- 210000001519 tissue Anatomy 0.000 description 78
- 238000003795 desorption Methods 0.000 description 71
- 239000000306 component Substances 0.000 description 66
- 150000001875 compounds Chemical class 0.000 description 62
- 239000000126 substance Substances 0.000 description 57
- 239000012491 analyte Substances 0.000 description 47
- 239000012086 standard solution Substances 0.000 description 47
- 238000000926 separation method Methods 0.000 description 46
- 230000008569 process Effects 0.000 description 44
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- 239000007789 gas Substances 0.000 description 38
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 37
- 238000006243 chemical reaction Methods 0.000 description 34
- 238000005251 capillar electrophoresis Methods 0.000 description 32
- 239000000872 buffer Substances 0.000 description 30
- 239000004205 dimethyl polysiloxane Substances 0.000 description 29
- 239000011159 matrix material Substances 0.000 description 28
- 238000001514 detection method Methods 0.000 description 27
- 102000004169 proteins and genes Human genes 0.000 description 27
- 108090000623 proteins and genes Proteins 0.000 description 27
- 238000002347 injection Methods 0.000 description 26
- 239000007924 injection Substances 0.000 description 26
- 239000000243 solution Substances 0.000 description 26
- 238000004817 gas chromatography Methods 0.000 description 25
- 239000012855 volatile organic compound Substances 0.000 description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 24
- 229940079593 drug Drugs 0.000 description 23
- 239000003814 drug Substances 0.000 description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 18
- 230000008901 benefit Effects 0.000 description 18
- 229950011008 tetrachloroethylene Drugs 0.000 description 18
- 238000004811 liquid chromatography Methods 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 239000000284 extract Substances 0.000 description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 15
- 230000035945 sensitivity Effects 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 14
- 150000002500 ions Chemical class 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 229920001410 Microfiber Polymers 0.000 description 13
- 239000003658 microfiber Substances 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- PGZIDERTDJHJFY-UHFFFAOYSA-N 4-fluoro-7-nitro-2,1,3-benzoxadiazole Chemical compound [O-][N+](=O)C1=CC=C(F)C2=NON=C12 PGZIDERTDJHJFY-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 229960003529 diazepam Drugs 0.000 description 12
- 238000004949 mass spectrometry Methods 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 238000001179 sorption measurement Methods 0.000 description 11
- 239000012530 fluid Substances 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 230000004044 response Effects 0.000 description 10
- 229910001220 stainless steel Inorganic materials 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 9
- 230000008859 change Effects 0.000 description 9
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 239000013307 optical fiber Substances 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 238000011088 calibration curve Methods 0.000 description 8
- 238000001212 derivatisation Methods 0.000 description 8
- 238000013461 design Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 238000001962 electrophoresis Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 238000000769 gas chromatography-flame ionisation detection Methods 0.000 description 8
- 210000004872 soft tissue Anatomy 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 7
- 239000005350 fused silica glass Substances 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 239000012510 hollow fiber Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000001690 micro-dialysis Methods 0.000 description 7
- 239000006199 nebulizer Substances 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 6
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- -1 polypropylene Polymers 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000004445 quantitative analysis Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- 241000219094 Vitaceae Species 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000005684 electric field Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 235000021021 grapes Nutrition 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000000752 ionisation method Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 239000003463 adsorbent Substances 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 150000003862 amino acid derivatives Chemical class 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 238000002157 matrix-assisted laser desorption-ionisation imaging mass spectrometry Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 241000219095 Vitis Species 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 229910021538 borax Inorganic materials 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000009510 drug design Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- 238000001917 fluorescence detection Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 238000001215 fluorescent labelling Methods 0.000 description 3
- 239000011491 glass wool Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 229940078552 o-xylene Drugs 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000004094 preconcentration Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 235000010339 sodium tetraborate Nutrition 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- QBVXKDJEZKEASM-UHFFFAOYSA-M tetraoctylammonium bromide Chemical compound [Br-].CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC QBVXKDJEZKEASM-UHFFFAOYSA-M 0.000 description 3
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 3
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- ZPQOPVIELGIULI-UHFFFAOYSA-N 1,3-dichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1 ZPQOPVIELGIULI-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 229930195714 L-glutamate Natural products 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000233805 Phoenix Species 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002156 adsorbate Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000005515 capillary zone electrophoresis Methods 0.000 description 2
- 239000012159 carrier gas Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000007614 genetic variation Effects 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- 229960002449 glycine Drugs 0.000 description 2
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 2
- 239000012155 injection solvent Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- IVSZLXZYQVIEFR-UHFFFAOYSA-N m-xylene Chemical group CC1=CC=CC(C)=C1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 238000004853 microextraction Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229960002640 nordazepam Drugs 0.000 description 2
- AKPLHCDWDRPJGD-UHFFFAOYSA-N nordazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)CN=C1C1=CC=CC=C1 AKPLHCDWDRPJGD-UHFFFAOYSA-N 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229960004535 oxazepam Drugs 0.000 description 2
- ADIMAYPTOBDMTL-UHFFFAOYSA-N oxazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1 ADIMAYPTOBDMTL-UHFFFAOYSA-N 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000013214 routine measurement Methods 0.000 description 2
- 238000011896 sensitive detection Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- SGNXVBOIDPPRJJ-PSASIEDQSA-N 1-[(1r,6r)-9-azabicyclo[4.2.1]non-4-en-5-yl]ethanone Chemical compound CC(=O)C1=CCC[C@@H]2CC[C@H]1N2 SGNXVBOIDPPRJJ-PSASIEDQSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- SGNXVBOIDPPRJJ-UHFFFAOYSA-N Anatoxin a Natural products CC(=O)C1=CCCC2CCC1N2 SGNXVBOIDPPRJJ-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241001631457 Cannula Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000005578 Rivina humilis Species 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102400000096 Substance P Human genes 0.000 description 1
- 101800003906 Substance P Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004164 analytical calibration Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000003130 blood coagulation factor inhibitor Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229940075397 calomel Drugs 0.000 description 1
- 238000000533 capillary isoelectric focusing Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 239000002359 drug metabolite Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000005370 electroosmosis Methods 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 239000003256 environmental substance Substances 0.000 description 1
- 229920006335 epoxy glue Polymers 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000004868 gas analysis Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002308 glutamine derivatives Chemical class 0.000 description 1
- 150000002332 glycine derivatives Chemical class 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000007770 graphite material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007235 immunity generation Effects 0.000 description 1
- 238000010249 in-situ analysis Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000005061 intracellular organelle Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000003189 isokinetic effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000001679 laser desorption electrospray ionisation Methods 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- MHCFAGZWMAWTNR-UHFFFAOYSA-M lithium perchlorate Chemical compound [Li+].[O-]Cl(=O)(=O)=O MHCFAGZWMAWTNR-UHFFFAOYSA-M 0.000 description 1
- 229910001486 lithium perchlorate Inorganic materials 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 150000003147 proline derivatives Chemical class 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000004808 supercritical fluid chromatography Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/405—Concentrating samples by adsorption or absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3403—Needle locating or guiding means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N2030/009—Extraction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/062—Preparation extracting sample from raw material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Sampling And Sample Adjustment (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Structures Of Non-Positive Displacement Pumps (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36421402P | 2002-03-11 | 2002-03-11 | |
| US39330902P | 2002-07-03 | 2002-07-03 | |
| US42100102P | 2002-10-25 | 2002-10-25 | |
| US42151002P | 2002-10-28 | 2002-10-28 | |
| US42783302P | 2002-11-21 | 2002-11-21 | |
| PCT/CA2003/000311 WO2003075772A2 (en) | 2002-03-11 | 2003-03-06 | Micro-devices and analytical procedures for investigation of biological systems |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005519669A JP2005519669A (ja) | 2005-07-07 |
| JP2005519669A5 JP2005519669A5 (https=) | 2006-04-20 |
| JP4381820B2 true JP4381820B2 (ja) | 2009-12-09 |
Family
ID=27808906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003574050A Expired - Fee Related JP4381820B2 (ja) | 2002-03-11 | 2003-03-06 | 生体組織検査用マイクロ抽出装置 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7384794B2 (https=) |
| EP (1) | EP1482840B1 (https=) |
| JP (1) | JP4381820B2 (https=) |
| AT (1) | ATE416675T1 (https=) |
| AU (1) | AU2003208226A1 (https=) |
| DE (1) | DE60325180D1 (https=) |
| WO (1) | WO2003075772A2 (https=) |
Families Citing this family (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017193213A1 (en) | 2016-05-10 | 2017-11-16 | Jp Scientific Limited | System and method for desorbing and detecting an analyte sorbed on a solid phase microextraction device |
| US20090026122A1 (en) | 2002-03-11 | 2009-01-29 | Janusz | Biocompatible solid-phase microextraction coatings and methods for their preparation |
| US20170241877A1 (en) * | 2002-03-11 | 2017-08-24 | Janusz B. Pawliszyn | System and method for desorbing and detecting an analyte sorbed on a solid phase microextraction device |
| DE60325180D1 (de) * | 2002-03-11 | 2009-01-22 | Janusz B Pawliszyn | Mikrovorrichtungen zur untersuchung von biologischen systemen |
| US8598325B2 (en) | 2002-03-11 | 2013-12-03 | Janusz B. Pawliszyn | Solid-phase microextraction coatings and methods for their preparation |
| US9733234B2 (en) | 2002-03-11 | 2017-08-15 | Jp Scientific Limited | Probe for extraction of molecules of interest from a sample |
| US7232689B2 (en) * | 2002-03-11 | 2007-06-19 | Pawliszyn Janusz B | Calibration procedure for investigating biological systems |
| US9870907B2 (en) | 2002-03-11 | 2018-01-16 | Jp Scientific Limited | Probe for extraction of molecules of interest from a sample |
| US20040195503A1 (en) * | 2003-04-04 | 2004-10-07 | Taeman Kim | Ion guide for mass spectrometers |
| EG23584A (en) * | 2003-11-11 | 2006-09-11 | Ali Mokhtar Al-Hossary Amr | Elimination of myoglobin from blood using an i v filter |
| JP4320342B2 (ja) * | 2004-08-17 | 2009-08-26 | 独立行政法人科学技術振興機構 | 希土類蛍光錯体を用いた標識方法と分析検出法 |
| GB0510171D0 (en) * | 2005-05-18 | 2005-06-22 | Mass Spec Analytical Ltd | Mass spectrometer apparatus |
| US7645286B2 (en) | 2005-05-20 | 2010-01-12 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
| US8668705B2 (en) | 2005-05-20 | 2014-03-11 | Neotract, Inc. | Latching anchor device |
| US9504461B2 (en) | 2005-05-20 | 2016-11-29 | Neotract, Inc. | Anchor delivery system |
| US10925587B2 (en) | 2005-05-20 | 2021-02-23 | Neotract, Inc. | Anchor delivery system |
| US8603106B2 (en) | 2005-05-20 | 2013-12-10 | Neotract, Inc. | Integrated handle assembly for anchor delivery system |
| US10195014B2 (en) | 2005-05-20 | 2019-02-05 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US9549739B2 (en) | 2005-05-20 | 2017-01-24 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US8628542B2 (en) | 2005-05-20 | 2014-01-14 | Neotract, Inc. | Median lobe destruction apparatus and method |
| ITFI20050194A1 (it) * | 2005-09-16 | 2007-03-17 | Esposti Filippo Degli | Apparecchiatura di campionamento automatico per microestrazione in fase solida (spme) |
| US20080023630A1 (en) * | 2005-11-22 | 2008-01-31 | Ciphergen Biosystems Inc. | Polymer probe doped with conductive material for mass spectrometry |
| JP2007205867A (ja) * | 2006-02-01 | 2007-08-16 | Shinwa Kako Kk | アルデヒド・ケトン類分析用繊維充填ニードル、分析装置及び分析方法 |
| US20070259445A1 (en) * | 2006-05-05 | 2007-11-08 | Blas Cerda | Quantitative analysis of surface-derived samples using mass spectrometry |
| US10434492B2 (en) * | 2007-01-26 | 2019-10-08 | Sigma-Aldrich Co. Llc | Compositions and methods for solid phase extraction of lipids |
| US10928366B2 (en) * | 2007-01-26 | 2021-02-23 | Sigma-Aldrich Co. Llc | Compositions and methods for combining protein precipitation and solid phase extraction |
| US8088097B2 (en) | 2007-11-21 | 2012-01-03 | Glumetrics, Inc. | Use of an equilibrium intravascular sensor to achieve tight glycemic control |
| US7728287B2 (en) | 2007-03-01 | 2010-06-01 | Lawrence Livermore National Security, Llc | Imaging mass spectrometer with mass tags |
| US20100168609A1 (en) * | 2007-03-14 | 2010-07-01 | Ogeno Gmbh | Biopsy device for the enrichment of tissue, cells, or analytes |
| CA2686065A1 (en) | 2007-05-10 | 2008-11-20 | Glumetrics, Inc. | Equilibrium non-consuming fluorescence sensor for real time intravascular glucose measurement |
| JP5395076B2 (ja) * | 2008-07-22 | 2014-01-22 | アークレイ株式会社 | キャピラリー電気泳動法による分析装置および分析方法 |
| US9500572B2 (en) | 2009-04-30 | 2016-11-22 | Purdue Research Foundation | Sample dispenser including an internal standard and methods of use thereof |
| US20110077477A1 (en) | 2009-09-30 | 2011-03-31 | Glumetrics, Inc. | Sensors with thromboresistant coating |
| DE112010004778A5 (de) * | 2009-10-20 | 2013-03-14 | Ogeno Gmbh | Biopsie-instrument umfassend ein magnetisches element |
| US8467843B2 (en) | 2009-11-04 | 2013-06-18 | Glumetrics, Inc. | Optical sensor configuration for ratiometric correction of blood glucose measurement |
| WO2011137178A1 (en) * | 2010-04-27 | 2011-11-03 | Glumetrics, Inc. | Deployment system and method for optical analyte sensor |
| US20120228490A1 (en) * | 2011-03-13 | 2012-09-13 | Excellims Corporation | Apparatus and method for ion mobility spectrometry and sample introduction |
| US8895918B2 (en) * | 2011-06-03 | 2014-11-25 | Purdue Research Foundation | Ion generation using modified wetted porous materials |
| WO2013036585A1 (en) * | 2011-09-06 | 2013-03-14 | The Trustees Of The University Of Pennsylvania | Activation and expansion of t cell subsets using biocompatible solid substrates with tunable rigidity |
| US10292801B2 (en) | 2012-03-29 | 2019-05-21 | Neotract, Inc. | System for delivering anchors for treating incontinence |
| CA2870439C (en) * | 2012-04-19 | 2018-02-06 | New Objective, Inc. | Method and apparatus for combined sample preparation and nanoelectrospray ionization mass spectrometry |
| US10130353B2 (en) | 2012-06-29 | 2018-11-20 | Neotract, Inc. | Flexible system for delivering an anchor |
| KR101393125B1 (ko) | 2012-07-20 | 2014-05-08 | 김기수 | 진피추출기 |
| US9733228B2 (en) | 2013-01-31 | 2017-08-15 | Purdue Research Foundation | Methods of analyzing crude oil |
| WO2014120411A1 (en) | 2013-01-31 | 2014-08-07 | Purdue Research Foundation | Systems and methods for analyzing an extracted sample |
| WO2014209474A1 (en) | 2013-06-25 | 2014-12-31 | Purdue Research Foundation | Mass spectrometry analysis of microorganisms in samples |
| JP6061302B2 (ja) * | 2013-06-26 | 2017-01-18 | 国立大学法人浜松医科大学 | 試料分析装置 |
| EP3129464B1 (en) | 2014-04-10 | 2019-08-28 | The Trustees of Columbia University in the City of New York | Methods, compositions, and systems for activation and expansion of cells |
| US9786478B2 (en) | 2014-12-05 | 2017-10-10 | Purdue Research Foundation | Zero voltage mass spectrometry probes and systems |
| CN107960130A (zh) | 2015-02-06 | 2018-04-24 | 普度研究基金会 | 探针、系统、盒及其使用方法 |
| WO2016134324A1 (en) * | 2015-02-20 | 2016-08-25 | Neoteryx, Llc | Method and apparatus for acquiring blood for testing |
| US10734216B2 (en) | 2015-05-11 | 2020-08-04 | The University Of North Carolina At Chapel Hill | Pressure driven fluidic injection for chemical separations by electrophoresis |
| US9606082B2 (en) | 2015-05-11 | 2017-03-28 | The University Of North Carolina At Chapel Hill | Pressure driven microfluidic injection for chemical separations |
| US10191061B2 (en) | 2015-08-20 | 2019-01-29 | King Fahd University Of Petroleum And Minerals | Microwave-assisted headspace liquid-phase microextraction of an analyte |
| WO2017040359A1 (en) | 2015-08-28 | 2017-03-09 | Indiana University Research And Technology Corporation | Atmospheric-pressure ionization and fragmentation of molecules for structural elucidation |
| US9728387B2 (en) | 2015-10-20 | 2017-08-08 | The University Of North Carolina At Chapel Hill | Solid phase extraction with capillary electrophoresis |
| JP6930986B2 (ja) | 2016-03-02 | 2021-09-01 | ジェイ・ピィ・サイエンティフィック・リミテッドＪｐ Ｓｃｉｅｎｔｉｆｉｃ Ｌｉｍｉｔｅｄ | サンプルから成分を抽出するための方法および装置 |
| JP6930978B2 (ja) | 2016-03-02 | 2021-09-01 | ジェイ・ピィ・サイエンティフィック・リミテッドＪｐ Ｓｃｉｅｎｔｉｆｉｃ Ｌｉｍｉｔｅｄ | 固相マイクロ抽出用コーティング |
| CN114544312A (zh) * | 2016-06-03 | 2022-05-27 | 普度研究基金会 | 用于分析使用吸附材料从样品中提取的分析物的系统和方法 |
| CN106093067B (zh) * | 2016-07-27 | 2018-08-14 | 温州职业技术学院 | 一种采血针自动组装机的检测装置 |
| US10345201B2 (en) | 2016-08-28 | 2019-07-09 | Alireza Ghiasvand | Polypyrrole/graphene oxide nanocomposite-coated fiber located in a capillary tube reinforced by a vacuum system for assessment of oxidative stability of edible oils |
| US11092522B2 (en) | 2017-03-01 | 2021-08-17 | Janusz Pawliszyn | Devices to facilitate sampling with thin film solid phase microextraction |
| CN106959349B (zh) | 2017-04-17 | 2019-04-26 | 武汉大学 | 一种微柱富集进样方法 |
| SG11202005766XA (en) | 2017-12-23 | 2020-07-29 | Neotract Inc | Expandable tissue engagement apparatus and method |
| EP3578972A1 (en) * | 2018-06-06 | 2019-12-11 | Blink AG | A device for fractionating a suspension sample |
| US12105062B2 (en) * | 2018-09-05 | 2024-10-01 | Bae Systems Information And Electronic Systems Integration Inc. | Carbide-derived carbon for solid-phase micro extraction media |
| WO2020096827A1 (en) | 2018-11-07 | 2020-05-14 | Neotract, Inc. | System for delivery of a fiducial marker |
| CN109223136A (zh) * | 2018-11-20 | 2019-01-18 | 林平珍 | 一种新型妇产科用羊水穿刺定位装置 |
| AU2020298543A1 (en) * | 2019-07-01 | 2022-01-06 | Perkinelmer U.S. Llc | PDMS granular coated vial |
| JP7348626B2 (ja) * | 2019-07-17 | 2023-09-21 | 国立大学法人山梨大学 | 生体試料の状態評価装置、システム、方法、およびプログラム |
| EP4018178B1 (en) * | 2019-08-20 | 2025-07-30 | Restek Corporation | Solid phase microextraction system |
| JP7739288B2 (ja) | 2019-11-27 | 2025-09-16 | レステック・コーポレーション | 固相マイクロ抽出装置および形成方法 |
| CN111297451A (zh) * | 2020-03-23 | 2020-06-19 | 钟琼 | 一种肿瘤科用穿刺定位器 |
| FI3989844T3 (fi) | 2020-08-03 | 2023-11-20 | Teleflex Life Sciences Ltd | Kahva ja patruunajärjestelmä lääketieteellisiin toimenpiteisiin |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4476231A (en) | 1981-07-22 | 1984-10-09 | International Remote Imaging Systems, Inc. | Method of analyzing the distribution of a reagent between particles and liquid in a suspension |
| US4616652A (en) * | 1983-10-19 | 1986-10-14 | Advanced Cardiovascular Systems, Inc. | Dilatation catheter positioning apparatus |
| US5120510A (en) * | 1986-10-10 | 1992-06-09 | Minnesota Mining And Manufacturing Company | Sensor and method for sensing the concentration of a component in a medium |
| US5047437A (en) | 1988-11-23 | 1991-09-10 | American Cyanamid | Porous polyacrylonitrile beads and process for their production |
| US5691206A (en) * | 1990-04-02 | 1997-11-25 | Pawliszyn; Janusz B. | Method and device for solid phase microextraction and desorption |
| GB9007356D0 (en) * | 1990-04-02 | 1990-05-30 | Pawliszyn Janusz B | Micro solid phase extraction with fused silica optical fibres |
| US5424187A (en) * | 1991-06-14 | 1995-06-13 | Board Of Regents Of The University Of Washington | Method of screening for arterial chlamydial granuloma |
| FI96379C (fi) * | 1992-10-16 | 1996-06-25 | Instrumentarium Oy | Menetelmä ja laitteisto näytteen analysoimiseksi |
| US5460813A (en) | 1993-04-05 | 1995-10-24 | National Jewish Center For Immunology And Respiratory Medicine | Method for treating Kawasaki syndrome by administration of an anti-TSST-1 agent which is not gamma globulin |
| US5464395A (en) * | 1994-04-05 | 1995-11-07 | Faxon; David P. | Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway |
| US5640470A (en) * | 1995-03-27 | 1997-06-17 | Abbott Laboratories | Fiber-optic detectors with terpolymeric analyte-permeable matrix coating |
| US5693228A (en) * | 1995-09-28 | 1997-12-02 | Varian Associates, Inc. | Method and device for vibration during solid phase microextraction |
| US6750031B1 (en) * | 1996-01-11 | 2004-06-15 | The United States Of America As Represented By The Secretary Of The Navy | Displacement assay on a porous membrane |
| US5830184A (en) * | 1996-03-06 | 1998-11-03 | Medical Components, Inc. | Composite catheter stabilizing devices, methods of making the same and catheter extracting device |
| US6103535A (en) | 1996-05-31 | 2000-08-15 | University Of Maryland | Optical fiber evanescent field excited fluorosensor and method of manufacture |
| US5798266A (en) * | 1996-08-27 | 1998-08-25 | K-Quay Enterprises, Llc | Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer |
| US6743180B1 (en) * | 1997-08-15 | 2004-06-01 | Rijksuniversiteit Leiden | Pressure sensor for use in an artery |
| JP3481828B2 (ja) * | 1997-08-26 | 2003-12-22 | 株式会社日立製作所 | 電気泳動分析装置，電気泳動分析方法及びそれに用いる試料容器 |
| US6360588B1 (en) | 1998-10-27 | 2002-03-26 | Edward Allan Ross | Materials and methods for the analysis of substances passing through a membrane |
| DE19905239B4 (de) * | 1999-02-02 | 2006-08-24 | Wendt, Oliver, Dipl.-Ing. | Positioniereinrichtung zur Positionierung von medizinischen Werkzeugen zur MR-gestützten Untersuchung und Behandlung von Körperteilen |
| US6815216B2 (en) | 1999-03-26 | 2004-11-09 | Gerstel Systemtechnik Gmbh & Co. Kg | Method for solid-phase microextraction and analysis, and a collector for this method |
| US6167297A (en) * | 1999-05-05 | 2000-12-26 | Benaron; David A. | Detecting, localizing, and targeting internal sites in vivo using optical contrast agents |
| GB0006046D0 (en) * | 2000-03-13 | 2000-05-03 | Univ Warwick | Time of flight mass spectrometry apparatus |
| AU2001246608A1 (en) * | 2000-03-17 | 2001-09-24 | Albert-Claude Benhamou | Device for in situ analysis and/or treatment with flexible rod |
| US20020034827A1 (en) | 2000-08-01 | 2002-03-21 | Rajendra Singh | Methods for solid phase nanoextraction and desorption |
| US20040005582A1 (en) | 2000-08-10 | 2004-01-08 | Nanobiodynamics, Incorporated | Biospecific desorption microflow systems and methods for studying biospecific interactions and their modulators |
| JP2004535563A (ja) | 2001-04-26 | 2004-11-25 | ヴァリアン インコーポレーテッド | 中空繊維膜のサンプル調製デバイス |
| US6871556B2 (en) * | 2001-07-27 | 2005-03-29 | The Regents Of The University Of California | Porous protective solid phase micro-extractor sheath |
| US20030135195A1 (en) * | 2002-01-16 | 2003-07-17 | Oscar Jimenez | Highly lubricious hydrophilic coating utilizing dendrimers |
| WO2003076927A1 (en) * | 2002-03-05 | 2003-09-18 | North Carolina State University | Method and apparatus for determining a molecular descriptor of absorption for a candidate compound |
| US7232689B2 (en) * | 2002-03-11 | 2007-06-19 | Pawliszyn Janusz B | Calibration procedure for investigating biological systems |
| DE60325180D1 (de) * | 2002-03-11 | 2009-01-22 | Janusz B Pawliszyn | Mikrovorrichtungen zur untersuchung von biologischen systemen |
| US7259019B2 (en) * | 2002-03-11 | 2007-08-21 | Pawliszyn Janusz B | Multiple sampling device and method for investigating biological systems |
| KR101107765B1 (ko) | 2002-08-06 | 2012-01-25 | 싸이퍼젠 바이오시스템즈, 인코포레이티드 | 난소암의 검출을 위한 생물 마커의 용도 |
| US7981362B2 (en) | 2003-11-04 | 2011-07-19 | Meso Scale Technologies, Llc | Modular assay plates, reader systems and methods for test measurements |
-
2003
- 2003-03-06 DE DE60325180T patent/DE60325180D1/de not_active Expired - Lifetime
- 2003-03-06 US US10/506,827 patent/US7384794B2/en not_active Expired - Lifetime
- 2003-03-06 AU AU2003208226A patent/AU2003208226A1/en not_active Abandoned
- 2003-03-06 WO PCT/CA2003/000311 patent/WO2003075772A2/en not_active Ceased
- 2003-03-06 AT AT03706179T patent/ATE416675T1/de not_active IP Right Cessation
- 2003-03-06 JP JP2003574050A patent/JP4381820B2/ja not_active Expired - Fee Related
- 2003-03-06 EP EP03706179A patent/EP1482840B1/en not_active Expired - Lifetime
-
2010
- 2010-11-03 US US12/938,876 patent/US8114660B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005519669A (ja) | 2005-07-07 |
| WO2003075772A3 (en) | 2004-02-05 |
| ATE416675T1 (de) | 2008-12-15 |
| DE60325180D1 (de) | 2009-01-22 |
| US8114660B2 (en) | 2012-02-14 |
| EP1482840B1 (en) | 2008-12-10 |
| US20050118599A1 (en) | 2005-06-02 |
| WO2003075772A2 (en) | 2003-09-18 |
| US20110104027A1 (en) | 2011-05-05 |
| EP1482840A2 (en) | 2004-12-08 |
| AU2003208226A1 (en) | 2003-09-22 |
| US7384794B2 (en) | 2008-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4381820B2 (ja) | 生体組織検査用マイクロ抽出装置 | |
| US8008064B2 (en) | Calibration procedure for investigating biological systems | |
| US7259019B2 (en) | Multiple sampling device and method for investigating biological systems | |
| Zhang et al. | Ambient ionization and miniature mass spectrometry systems for disease diagnosis and therapeutic monitoring | |
| Pirro et al. | Direct drug analysis from oral fluid using medical swab touch spray mass spectrometry | |
| Laskin et al. | Ambient mass spectrometry imaging using direct liquid extraction techniques | |
| Fang et al. | Coupling solid-phase microextraction with ambient mass spectrometry: Strategies and applications | |
| Klepárník et al. | Recent advances in the development of single cell analysis—A review | |
| EP3423808B1 (en) | Method and instrument for extracting a component from a sample | |
| Guzman | Determination of immunoreactive gonadotropin-releasing hormone in serum and urine by on-line immunoaffinity capillary electrophoresis coupled to mass spectrometry | |
| Lapainis et al. | Contributions of capillary electrophoresis to neuroscience | |
| US20040226822A1 (en) | Multi-dimensional electrophoresis apparatus | |
| US9595428B2 (en) | Cellular probe device, system and analysis method | |
| Arce et al. | Sample-introduction systems coupled to ion-mobility spectrometry equipment for determining compounds present in gaseous, liquid and solid samples | |
| JP6492099B2 (ja) | 不混和性抽出溶媒を用いる抽出サンプルの分析 | |
| CN109564147B (zh) | 用于分析使用吸附材料从样品中提取的分析物的系统和方法 | |
| WO2005095942A1 (ja) | レーザーアブレーションを用いた生体試料の分析方法およびその装置 | |
| Chen et al. | Biosensors for single-cell metabolomic characterization | |
| CN113720894A (zh) | 一种直接采样电离分析系统及方法、应用 | |
| CA2478970C (en) | Micro-devices and analytical procedures for investigation of biological systems | |
| Wu et al. | Liquid‐phase microextraction for rapid AP‐MALDI and quantitation of nortriptyline in biological matrices | |
| Verma et al. | Solid-phase microextraction | |
| JP5544759B2 (ja) | 質量分析を用いた試料の分析方法 | |
| EP4359754B1 (en) | Method for detecting at least one analyte in a sample | |
| Vuckovic | Solid-phase microextraction as sample preparation method for metabolomics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060303 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060303 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090210 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090508 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090515 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090610 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090901 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090916 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121002 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4381820 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131002 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |